LORLATINIB for Brain neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where LORLATINIB was used for Brain neoplasm malignant.
Most Reported Side Effects for LORLATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 1,050 | 19.1% | 1,047 | 74 |
| Neoplasm progression | 633 | 11.5% | 278 | 155 |
| Off label use | 394 | 7.2% | 97 | 87 |
| Weight increased | 306 | 5.6% | 17 | 46 |
| Hallucination | 290 | 5.3% | 21 | 56 |
| Blood cholesterol increased | 281 | 5.1% | 32 | 47 |
| Dyspnoea | 223 | 4.1% | 49 | 113 |
| Oedema peripheral | 198 | 3.6% | 29 | 62 |
| Oedema | 195 | 3.5% | 17 | 36 |
| Fatigue | 188 | 3.4% | 44 | 49 |
| Peripheral swelling | 164 | 3.0% | 21 | 30 |
| Cognitive disorder | 158 | 2.9% | 11 | 31 |
| Hypercholesterolaemia | 157 | 2.9% | 19 | 43 |
| Blood triglycerides increased | 145 | 2.6% | 19 | 35 |
| Neuropathy peripheral | 142 | 2.6% | 3 | 17 |
Other Indications for LORLATINIB
Non-small cell lung cancer (968)
Lung neoplasm malignant (810)
Non-small cell lung cancer metastatic (285)
Lung adenocarcinoma (269)
Lung cancer metastatic (161)
Neuroblastoma (91)
Product used for unknown indication (88)
Non-small cell lung cancer stage iv (73)
Neoplasm malignant (58)
Lung carcinoma cell type unspecified stage iv (54)
Other Drugs Used for Brain neoplasm malignant
PROCARBAZINE (2,283)
TEMOZOLOMIDE (2,202)
BEVACIZUMAB (740)
TRAMETINIB DIMETHYL SULFOXIDE (317)
LOMUSTINE (291)
THALIDOMIDE (195)
DABRAFENIB (189)
IVOSIDENIB (140)
SELINEXOR (136)
AVAPRITINIB (122)